Litigation, Risk to Reputation May Come From Scrutiny of Doctor Payment Data

Newly released Open Payments data may have wide-ranging effects on both physicians and drug and device manufacturers who make the payments to doctors, including an increase in qui tam filings, as well as the potential for reputational risks to physicians, attorneys told Bloomberg BNA.

Elizabeth B. Carder-Thompson, an attorney with Reed Smith, told Bloomberg BNA Sept. 30 that she’s concerned the public release the same day of Open Payments data will be mined for qui tam lawsuits under the False Claims Act.

“I’m concerned the profit incentive, coupled with data with no context, will lead to more frivolous lawsuits,” Carder-Thompson ...